Lymphoproliferative Disorders clinical trials at UC Davis

2 research studies open to eligible people

Showing trials for

  • Tabelecleucel in Participants With Epstein-barr Virus (EBV)-Associated Diseases

    open to all eligible people

    The purpose of this study is to assess the efficacy and safety of tabelecleucel in participants with EBV-associated diseases.

    Sacramento 5389489, California 5332921 and other locations

  • Project: Every Child for Younger Patients With Cancer

    “A REGISTRY, ELIGIBILITY SCREENING, BIOLOGY AND OUTCOME STUDY”

    open to eligible people ages up to 25 years

    This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.

    Sacramento 5389489, California 5332921 and other locations

Our lead scientists for Lymphoproliferative Disorders research studies include .

Last updated: